Literature DB >> 7771026

Salvage radical prostatectomy after failed transperineal cryotherapy: histologic findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images.

S A Grampsas1, G J Miller, E D Crawford.   

Abstract

OBJECTIVES: This study evaluates the potential for salvage radical prostatectomy after failure of transrectal ultrasound (TRUS)-guided percutaneous cryosurgical ablation of the prostate. An additional purpose was to determine the accuracy of intraoperative TRUS to delineate the extent of freeze destruction that results from cryosurgery.
METHODS: Six patients with biopsy-confirmed, Stage T3 prostate cancer underwent salvage radical prostatectomy 3 to 10 months after failing prostate cryosurgery. Zones of freeze destruction (resolving coagulative necrosis) and residual adenocarcinoma were mapped on the coverslips of whole-mount sections. Histologically proven zones of freeze destruction correlating to successfully treated prostatic tissue were compared to the hypoechoic ice ball treatment zones seen on intraoperative TRUS images.
RESULTS: The whole mounts were found to contain necrotic areas of cryodestruction that appeared much smaller than predicted by intraoperative ultrasound. Each of the cases also contained residual viable adenocarcinoma. All patients are alive and clinically free of localized disease 0.5 to 12 months after salvage radical prostatectomy.
CONCLUSIONS: Salvage radical prostatectomy offers an effective treatment option in patients who have failed transperineal cryosurgery of the prostate. Intraoperative TRUS predicted that the entire prostate would show freeze destruction. Whole-mount analysis, however, revealed areas of remaining unaffected adenocarcinoma and normal prostatic parenchyma. TRUS, therefore, overstimates the area of prostatic tissue destroyed by extreme cold. This finding challenges the assumption that the entire prostate is lethally frozen when its boundaries are included within the hypoechoic ice ball witnessed on TRUS.

Entities:  

Mesh:

Year:  1995        PMID: 7771026     DOI: 10.1016/s0090-4295(99)80111-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Cancer cryotherapy: evolution and biology.

Authors:  Dan Theodorescu
Journal:  Rev Urol       Date:  2004

Review 2.  Focal therapy in prostate cancer: modalities, findings and future considerations.

Authors:  Uri Lindner; John Trachtenberg; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-09-14       Impact factor: 14.432

3.  The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.

Authors:  W van den Bos; D M de Bruin; R R Jurhill; C D Savci-Heijink; B G Muller; I M Varkarakis; A Skolarikos; P J Zondervan; M P Laguna-Pes; H Wijkstra; T M de Reijke; J J M C H de la Rosette
Journal:  World J Urol       Date:  2015-08-22       Impact factor: 4.226

4.  Salvage robot-assisted radical prostatectomy with pelvic lymph node dissection after cryotherapy failure.

Authors:  Esequiel Rodriguez; Douglas W Skarecky; Thomas E Ahlering
Journal:  J Robot Surg       Date:  2007-01-19

5.  MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.

Authors:  Willemien van den Bos; D M de Bruin; A van Randen; M R W Engelbrecht; A W Postema; B G Muller; I M Varkarakis; A Skolarikos; C D Savci-Heijink; R R Jurhill; P J Zondervan; M P Laguna Pes; H Wijkstra; T M de Reijke; J J M C H de la Rosette
Journal:  Eur Radiol       Date:  2015-10-08       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.